TUBULOGLOMERULAR EVALUATION IN VISCERAL LEISHMANIASIS BEFORE AND AFTER TREATMENT WITH PENTAVALENT ANTIMONIAL

被引:0
|
作者
Oliveira, Michelle J. C. [1 ]
Silva Junior, Geraldo [1 ,2 ]
Sampaio, Aline M. [1 ]
Montenegro, Barbara [1 ]
Alves, Marilia P. [1 ]
Henn, Guilherme A. L. [1 ]
Rocha, Hermano A. L. [1 ]
Meneses, Gdayllon C. [1 ]
Martins, Alice M. C. [1 ]
Sanches, Talita R. [3 ]
Andrade, Lucia C. [3 ]
Seguro, Antonio C. [3 ]
Liborio, Alexandre B. [1 ]
Daher, Elizabeth F. [1 ]
机构
[1] Univ Fed Ceara, Fortaleza, Ceara, Brazil
[2] Univ Fortaleza, Fortaleza, Ceara, Brazil
[3] Univ Sao Paulo, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MP089
引用
收藏
页码:357 / 358
页数:2
相关论文
共 50 条
  • [1] NEUROLOGIC TOXICITY BY PENTAVALENT ANTIMONIAL DRUGS DURING TREATMENT OF VISCERAL LEISHMANIASIS
    DELESTAL, PL
    CALABRESE, S
    ZABALA, JA
    MARTIN, T
    MEDICINA CLINICA, 1994, 102 (07): : 276 - 277
  • [2] PENTAVALENT ANTIMONIAL TREATMENT IN MUCOSAL LEISHMANIASIS
    SAMPAIO, RNR
    SAMPAIO, JHD
    MARSDEN, PD
    LANCET, 1985, 1 (8437): : 1096 - 1097
  • [3] Renal Function Improvement with Pentavalent Antimonial Agents in Patients with Visceral Leishmaniasis
    Daher, Elizabeth F.
    Rocha, Natalia A.
    Oliveira, Michelle J. C.
    Franco, Luiz F. L. G.
    Oliveira, Jobson L.
    Silva Junior, Geraldo B.
    Abreu, Krasnalhia Livia S.
    Henn, Guilherme A. L.
    Martins, Alice M. C.
    Liborio, Alexandre B.
    AMERICAN JOURNAL OF NEPHROLOGY, 2011, 33 (04) : 332 - 336
  • [4] Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial
    Oliveira, Rodrigo A.
    Lima, Claudio G.
    Mota, Rosa M. S.
    Martins, Alice M. C.
    Sanches, Talita R.
    Seguro, Antonio C.
    Andrade, Lucia C.
    Silva Junior, Geraldo B.
    Liborio, Alexandre B.
    Daher, Elizabeth F.
    BMC NEPHROLOGY, 2012, 13
  • [5] Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial
    Rodrigo A Oliveira
    Cláudio G Lima
    Rosa Ms Mota
    Alice Mc Martins
    Talita R Sanches
    Antônio C Seguro
    Lúcia C Andrade
    Geraldo B Silva Junior
    Alexandre B Libório
    Elizabeth F Daher
    BMC Nephrology, 13
  • [6] AMPHOTERICIN-B FOR VISCERAL LEISHMANIASIS RESISTANT TO PENTAVALENT ANTIMONIAL DRUGS IN AIDS
    RODILLA, F
    MAGRANER, J
    AZNAR, J
    OROVITG, F
    ALCACER, F
    COLOMINA, J
    FERRIOLS, F
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (11) : 1305 - 1305
  • [7] A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use
    Oliveira, MC
    de Amorim, RFB
    Freitas, RD
    Costa, ADL
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2005, 38 (03) : 258 - 260
  • [8] PANCREATITIS INDUCED BY PENTAVALENT ANTIMONIAL AGENTS DURING TREATMENT OF LEISHMANIASIS
    GASSER, RA
    MAGILL, AJ
    OSTER, CN
    FRANKE, ED
    GROGL, M
    BERMAN, JD
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) : 83 - 90
  • [9] Visceral leishmaniasis unresponsive to antimonial drugs: Risk factors and treatment
    Piarroux, R
    Garnier, JM
    Gambarelli, F
    Dumon, H
    Kaplanski, S
    Unal, D
    ARCHIVES DE PEDIATRIE, 1996, 3 (04): : 352 - 356
  • [10] Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis
    Bosch, Marta Maristany
    Cuervo, Guillermo
    Martin, Elisabeth Matas
    de las Heras, Misericordia Veciana
    Perez, Jordi Pedro
    Yelamos, Sergio Martinez
    Fernandez, Nuria Sabe
    CLINICAL NEUROPHYSIOLOGY PRACTICE, 2021, 6 : 164 - 167